Developing a vaccine to treat triple negative breast cancer
Canadian Cancer Society, Université de Sherbrooke, Dr Lee-Hwa Tai, PhD
Dr Lee-Hwa Tai is pioneering a unique immunotherapy approach for treating one of the most challenging forms of breast cancer.
Charity Partner
Research Institute
Researcher
Dr Lee-Hwa Tai, PhD
Why should you donate to this project?
1 in 8 Canadian women are expected to be diagnosed with breast cancer in their lifetime. That's 27,900 women every year, with thousands more living with the disease.
A researcher with a solution:
Dr Lee-Hwa Tai, an esteemed researcher with expertise in immunotherapy, is developing a vaccine to target the difficult-to-treat triple negative breast cancer. Learn more about the team >
A personalized approach to immunotherapy.
Personalized immunotherapy designs vaccines based on the unique characteristics of an individual’s cancer cells. This approach offers a more specialized and stronger treatment, especially for those who often don't respond to conventional therapies. Learn more about the research >
Explore more projects from Canadian Cancer Society
View projects